GORE® CARDIOFORM Septal Occluder and Antiplatelet medical management for reduction of recurrent stroke in patients with Patent Foremen Ovale (PFO): The REDUCE post approval study,
Role: PI,
W.L. Gore & Associates, Inc.,
(06/2024 - 06/2025)
Status: Approved
Impella®-Supported PCI in High-Risk Patients with Complex Coronary Artery Disease and Reduced Left Ventricular Function: The PROTECT IV Trial,
Role: Investigator,
ABIOMED, Inc.,
(01/2025 - 01/2026)
Status: Approved